Linked Life Data

16636494

Source:http://linkedlifedata.com/resource/pubmed/id/16636494

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2006-4-25
pubmed:abstractText
Suppression of implantable defibrillator discharges associated with ventricular tachyarrhythmia (VTA) has been reported for sotalol. This study aimed to investigate the efficacy of intravenous nifekalant hydrochloride in predicting the effects of oral sotalol.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
1346-9843
pubmed:author
pubmed:issnType
Print
pubmed:volume
70
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
583-7
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:year
2006
pubmed:articleTitle
Comparison of efficacy of sotalol and nifekalant for ventricular tachyarrhythmias.
pubmed:affiliation
Division of Clinical Pharmacology, Vanderbilt University School of Medicine, Nashville, TN 37232-0575, USA. hiroshi7@med.niigata-u.ac.jp
pubmed:publicationType
Journal Article, Clinical Trial, Comparative Study